Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
PODCAST | First void urine: revolutionizing potential non-invasive biomarker collection for clinical diagnostics LISTEN NOW

Video: Antibody drug–conjugates characterization (Waters Corporation)

21 May 2015
Chromatography MS (LC–MS/MS, HRMS, IMS)

This video discusses powerful analytical tools which can be used to interrogate and understand ADCs. In particular, it outlines:

  • Characterizing ADCs with hydrophobic interaction chromatography
  • Deriving DAR via native UPLC/MS
  • Resolving positional isomers by 2D UPLC/MS
  • Identifying conjugation by peptide mapping

Top content

  • Real-time liquid biopsy study aims to transform cancer treatment monitoring

Related tags

ADCs LC-MS MS
Previous article

Related articles

6 NOV 2015 CHROMATOGRAPHY
Elucidation of markers for monitoring morphine and its analogs in urine adulterated with pyridinium chlorochromate
13 MAR 2012 COLLABORATIONS AND MERGERS
Science and technology coming together to make a difference
11 APR 2013 CHROMATOGRAPHY
Thermo Fisher Scientific design data system that unites chromatography and MS technology
23 APR 2012 CHROMATOGRAPHY
New methodology for the development of chromatographic methods with bioanalytical application
11 OCT 2019 MS (LC–MS/MS, HRMS, IMS)
Besides quantitative applications what else can hybrid assay technology do that will be important to future biotherapeutic development?
23 NOV 2015 CHROMATOGRAPHY
Evaluating the impact of matrix effects on biomarker assay sensitivity
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone